Home › Immunoglobulin Light-chain Amyloidosis › Ohio › Cleveland
Immunoglobulin Light-chain Amyloidosis clinical trials in Cleveland, OH
3 studies for Immunoglobulin Light-chain Amyloidosis are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
RecruitingPhase 1/2
- Cleaveland Clinic, Cleveland
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
RecruitingPhase 1/2
- Research Site, Cleveland
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
RecruitingPhase 3
- Case Western Reserve University, Cleveland
Immunoglobulin Light-chain Amyloidosis trials in other cities
- Boston, MA7 studies
- Rochester, MN5 studies
- New York City, NY4 studies
- Durham, NC4 studies
- Columbus, OH3 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer43 studies
- Cancer (all types)36 studies
- Breast Cancer35 studies
- Prostate Cancer34 studies
- Heart Failure33 studies
- Ovarian Cancer30 studies
- Metastatic Cancer30 studies
- Lung Cancer26 studies
- Colorectal Cancer24 studies
- Cardiovascular Disease22 studies
- Endometrial Cancer20 studies
- Acute Myeloid Leukemia20 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.